Oculgen Biomedical Technology

Company

Shenzhen Oculgen Secures Over RMB 100 Million in Series A Funding

Fineline Cube Jan 11, 2025

Shenzhen Oculgen Biomedical Technology Co., Ltd. has successfully completed a Series A financing round, raising...

Company Drug

Novo Nordisk semaglutide Alzheimer’s biomarkers fail primary endpoint

Company Medical Device

Acotec V-otter Microcatheter Secures NMPA Approval for TACE Procedures

Company Deals

Youjia-Bio Tongee-Medical Nucleic-Acid-Drug Partnership Targets Diabetes

Company Drug

Fosun-Pharma FXS0887 ATR-Inhibitor Gets NMPA Phase 1 Nod